Concepedia
Statistics
Publications
35
Citations
2K
H-Index
25
Active since
1984
Affiliations
Biogen (United States)(Current)
Johnson & Johnson (United States)
United States Food and Drug Administration
Sterling Research Group (United States)
University of Wisconsin–Madison
Mark Rogge is an author at Biogen (United States) specializing in medicine, pharmacology, and pharmacotherapy.
Top concepts
MedicinePharmacologyPharmacotherapyPharmacokineticsImmunologyDrug DiscoveryDrug ResistanceHematologyThrombosisDrug Safety
Publications per year
1984–2022
Self-Emulsifying Drug Delivery Systems: Formulation and Biopharmaceutic Evaluation of an Investigational Lipophilic Compound
Susan A. Charman, William N. Charman, Mark Rogge et al. · Pharmaceutical Research · 1992 · 376 citations
Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses
Shuchean Chien, Mark Rogge, L. G. Gisclon et al. · Antimicrobial Agents and Chemotherapy · 1997 · 215 citations · Full text
Oral Levofloxacin, Therapeutic Drug Monitoring, Pharmacokinetic Profile +10
Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability
William N. Charman, Mark Rogge, Alexander W. Boddy et al. · The Journal of Clinical Pharmacology · 1993 · 141 citations
Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses
John Lettieri, Mark Rogge, Lee Kaiser et al. · Antimicrobial Agents and Chemotherapy · 1992 · 130 citations
Pharmacological Study, Antibiotics, Medicine +10
A Novel PEGylated Interferon Beta‐1a for Multiple Sclerosis: Safety, Pharmacology, and Biology
Xiao Hu, Larisa Miller, Sandra Richman et al. · The Journal of Clinical Pharmacology · 2011 · 122 citations
1–5 of 35